Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
申请人:Mewshaw Eric Richard
公开号:US20050009907A1
公开(公告)日:2005-01-13
This invention provides estrogen receptor modulators having the structure
where R
1
-R
5
are as defined in the specification; or a pharmaceutically acceptable salt thereof.
这项发明提供了具有以下结构的雌激素受体调节剂,其中R1-R5如规范中所定义;或其药学上可接受的盐。
[EN] ARYL-CARBALDEHYDE OXIME DERIVATIVES AND THEIR USE AS ESTROGENIC AGENTS<br/>[FR] DERIVES D'ARYLE-CARBALDEHYDE OXIME ET LEUR UTILISATION COMME AGENTS OESTROGENIQUES
申请人:WYETH CORP
公开号:WO2004103941A3
公开(公告)日:2005-01-20
ARYL-CARBALDEHYDE OXIME DERIVATIVES AND THEIR USE AS ESTROGENIC AGENTS
申请人:Wyeth
公开号:EP1633699A2
公开(公告)日:2006-03-15
US7157491B2
申请人:——
公开号:US7157491B2
公开(公告)日:2007-01-02
Synthesis of Biaryl Compounds Using Tandem Ruthenium-Catalyzed Ring-Closing Metathesis
Tandem ring‐closing enyne metathesis (RCEM)/ring‐closing olefin metathesis (RCM) of tetraenynes with Grubbs second‐generation catalyst, followed by elimination, was found to be a new and efficient synthetic approach to biaryl compounds. A preliminary asymmetric version of this approach, which used homochiral Ru–alkylidene catalysts, is also presented.